Skip to main content
Premium Trial:

Request an Annual Quote

GeneMachines Lays Off 25 Percent of Workforce

SAN FRANCISCO, June 17 - GeneMachines has laid off approximately 20 employees, mostly from manufacturing, in an effort to offset a drop in sales and allay costs, a company official told GenomeWeb today.


The reductions, which brings to 60 the total number of remaining employees, were made last week and reflected a need "to align expense with revenue," said Terry Allread, GeneMachines' new chief operating officer.

"We're off our revenue projections this year due to a general slow-down in the capital equipment industry," said Allread. "I think it's the economy across the board right now. People are being very cautious" in making new purchases, he said.


Allread said sales of oligo synthesis equipment was hit hardest compared to other GeneMachines tool lines, which includes microarrays. He said many of the company's customer complained that grant cycles were taking longer, leading to increased waiting periods for funds to make equipment purchases.


He said GeneMachines, a privately held company based in San Carlos, Calif., has no plans for further staff reductions.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.